4.2 Article

Distinct Claudin Expression Profiles of Hepatocellular Carcinoma and Metastatic Colorectal and Pancreatic Carcinomas

Journal

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 61, Issue 4, Pages 294-305

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1369/0022155413479123

Keywords

liver metastasis; hepatocellular carcinoma; tight junction; claudins

Categories

Funding

  1. Hungarian Scientific Research Found (OTKA) [K101435]
  2. National Development Agency of Hungary [TAMOP-4.2.1/B-09/1/KMR-2010-0001]

Ask authors/readers for more resources

Tight junction proteins, including claudins, are often dysregulated during carcinogenesis and tumor progression. Moreover, the claudin expression pattern usually varies between different tumor entities. We aimed to investigate claudin expression profiles of primary and metastatic liver malignancies. We analyzed claudin-1, -2, -3, -4, and -7 expression by quantitative immunohistochemistry and real-time RT-PCR, respectively. Twenty hepatocellular carcinomas (HCCs) and liver metastases of 20 colorectal adenocarcinomas (CRLMs) and 15 pancreatic adenocarcinomas (PLMs) were studied together with paired surrounding non-tumorous liver samples and 5 normal liver samples. Strong claudin-3 and -7 immunohistochemical positivities were detected in CRLM samples, each with significantly stronger staining when compared with HCC and PLM groups. Claudin-1 protein was found highly expressed in CRLM, in contrast to lower expression in PLM and HCC. CRLMs and PLMs also were strongly positive for claudin-4, while being virtually undetectable in HCC. Claudin-2 showed strong positivity in non-tumorous liver tissue, whereas significantly weaker positivity was observed in all tumors. Differences in mRNA expression were mostly similar to those found by immunohistochemistry. In conclusion, HCC and both CRLM and PLM display distinct claudin expression profiles, which might provide better understanding of the pathobiology of these lesions and might be used for differential diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Dual-Stained Cervical Cytology and Histology with Claudin-1 and Ki67

Timea Szekerczes, Adam Galamb, Adrienn Kocsis, Marta Benczik, Tibor Takacs, Attila Martonos, Balazs Jaray, Andras Kiss, Csaba Jeney, Miklos Nyiri, Zsuzsa Schaff, Gabor Sobel

PATHOLOGY & ONCOLOGY RESEARCH (2019)

Article Oncology

MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma

Gabor Lendvai, Timea Szekerczes, Benedek Gyongyosi, Krisztina Schlachter, Endre Kontsek, Adrian Pesti, Attila Patonai, Klara Werling, Ilona Kovalszky, Zsuzsa Schaff, Andras Kiss

PATHOLOGY & ONCOLOGY RESEARCH (2019)

Article Pathology

TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma

Jie Zhang, Pin Liu, Junyan Tao, Pan Wang, Yi Zhang, Xinhua Song, Li Che, Pavel Sumazin, Silvia Ribback, Andras Kiss, Zsuzsa Schaff, Antonio Cigliano, Frank Dombrowski, Carla Cossu, Rosa M. Pascale, Diego F. Calvisi, Satdarshan P. Monga, Xin Chen

AMERICAN JOURNAL OF PATHOLOGY (2019)

Article Oncology

Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases

Irene Coati, Gabor Lotz, Giuseppe Nicolo Fanelli, Stefano Brignola, Cristiano Lanza, Rocco Cappellesso, Antonio Pellino, Salvatore Pucciarelli, Gaya Spolverato, Vincenza Guzzardo, Giada Munari, Giovanni Zaninotto, Marco Scarpa, Luca Mastracci, Fabio Farinati, Stefano Realdon, Pierluigi Pilati, Sara Lonardi, Nicola Valeri, Massimo Rugge, Andras Kiss, Fotios Loupakis, Matteo Fassan

BRITISH JOURNAL OF CANCER (2019)

Article Gastroenterology & Hepatology

Helicobacter pylori heteroresistance to clarithromycin in adults-New data by in situ detection and improved concept

Eva Kocsmar, Ildiko Kocsmar, Gyorgy Miklos Buzas, Ildiko Szirtes, Judit Wacha, Alajos Takats, Istvan Hritz, Zsuzsa Schaff, Massimo Rugge, Matteo Fassan, Andras Kiss, Gabor Lotz

HELICOBACTER (2020)

Article Oncology

BGP-15 Protects Mitochondria in Acute, Acetaminophen Overdose Induced Liver Injury

Farkas Sarnyai, Timea Szekerczes, Miklos Csala, Balazs Sumegi, Andras Szarka, Zsuzsa Schaff, Jozsef Mandl

PATHOLOGY & ONCOLOGY RESEARCH (2020)

Article Medicine, General & Internal

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients

Tibor Szarvas, Michele J. Hoffmann, Csilla Olah, Eszter Szekely, Andras Kiss, Jochen Hess, Stephan Tschirdewahn, Boris Hadaschik, Vera Grotheer, Peter Nyirady, Anita Csizmarik, Melinda Varadi, Henning Reis

Summary: Chemotherapy resistance is a major issue in bladder cancer treatment. MMP-7 tissue and serum levels are associated with poor prognosis in patients undergoing platinum-based chemotherapy. Analysis of MMP-7 may help in optimizing therapeutic decisions for bladder cancer patients.

DIAGNOSTICS (2021)

Article Oncology

Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice

Andrea Reszegi, Katalin Karaszi, Gabor Toth, Kristof Rada, Lorand Vancza, Lilla Turiak, Zsuzsa Schaff, Andras Kiss, Laszlo Szilak, Gabor Szabo, Gabor Petovari, Anna Sebestyen, Katalin Dezso, Eszter Regos, Peter Tatrai, Kornelia Baghy, Ilona Kovalszky

Summary: Syndecan-1 plays a dual role in tumor development, either promoting or inhibiting tumors depending on the cancer type. In the context of liver cancer, transgenic expression of human syndecan-1 delayed tumor formation by downregulating lipid metabolism, inhibiting mTOR and beta-catenin pathways, and activating Foxo1 and p53 transcription factors. This oncoprotective effect was mediated by a beneficial modulation of lipid metabolism and molecular signaling pathways involved in cell cycle regulation and intermediary metabolism.

CANCERS (2021)

Article Genetics & Heredity

Molecular Characterization of Muellerian Tumors of the Urinary Tract

Nadina Ortiz-Bruechle, Sophie Wucherpfennig, Michael Rose, Stefan Garczyk, Simone Bertz, Arndt Hartmann, Henning Reis, Tibor Szarvas, Andras Kiss, Felix Bremmer, Reinhard Golz, Ruth Knuechel, Nadine T. Gaisa

Summary: This study characterized the molecular background of Muellerian tumors of the urinary tract and identified various single nucleotide alterations and copy number alterations in these rare tumors. The absence of TERT promoter mutations and PAX8 immunohistochemical positivity were suggested as key diagnostic features for these tumors.

GENES (2021)

Meeting Abstract Pathology

Which is the right assessment method for primary clarithromycin resistance? Resistance rates of eradication-naive and macrolide-naive Helicobacter pylori infected patients in a large scale study

E. Kocsmar, I. Kocsmar, M. Kramer, A. Szijarto, G. M. Buzas, L. Bene, I. Szirtes, Z. Kramer, K. Szenas, P. Fadgyas-Freyler, A. Kiss, Z. Schaff, G. Lotz

VIRCHOWS ARCHIV (2018)

Meeting Abstract Pathology

Degree of chromosomal abnormalities detected by UroVysion test predicts progression of non-muscle invasive bladder cancer

I. Kocsmar, G. Pajor, A. Sziraki, E. Kocsmar, B. Gyongyosi, E. Szekely, I. Kenessey, P. Nyirady, A. Kiss, Z. Schaff, P. Riesz, G. Lotz

VIRCHOWS ARCHIV (2018)

No Data Available